ZNF692 and osteosarcoma: These reports indicate that ZNF692 might be an oncogene in tumors, and consistently, we found that ZNF692 was higher in the high-risk group than in the low risk-group, and the higher expression of ZNF692 was associated with worse overall survival in osteosarcoma.